[A case of drug induced liver injury related pioglitazone].
Hisamochi
Akiko
A
Second Department of Medicine, Kurume University School of Medicine.
Kumashiro
Ryukichi
R
Koga
Yuriko
Y
Tanaka
Eisuke
E
Ide
Tatsuya
T
Hino
Teruko
T
Murashima
Shiro
S
Ogata
Kei
K
Kuwahara
Reiichiro
R
Koga
Hironori
H
Shishido
Shoichiro
S
Ueno
Takato
T
Sata
Michio
M
Eguchi
Takahisa
T
D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury; D065729:Cytochrome P-450 CYP2C9; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008875:Middle Aged; D000077205:Pioglitazone; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D000077205:Pioglitazone